Abstract
Environmental risk and protective factors in schizophrenia play a significant role in the development and course of the disorder. The following article reviews the current state of evidence linking a variety of environmental factors and their impact on the emergence of psychotic disorders. The environmental factors include pre- and perinatal insults, stress and trauma, family environment, and cannabis use. The review of evidence is followed by case examples and clinical applications to facilitate the integration of the evidence into clinical practice.
Keywords: Risk and protective factors, schizophrenia, prodromal states, psychosis, environmental factors, perinatal trauma, stress, family environment, cannabis use
Adolescent Psychiatry
Title:Environmental Risk and Protective Factors and Their Influence on the Emergence of Psychosis
Volume: 2 Issue: 2
Author(s): Danielle A. Schlosser, Rahel Pearson, Veronica B. Perez and Rachel L. Loewy
Affiliation:
Keywords: Risk and protective factors, schizophrenia, prodromal states, psychosis, environmental factors, perinatal trauma, stress, family environment, cannabis use
Abstract: Environmental risk and protective factors in schizophrenia play a significant role in the development and course of the disorder. The following article reviews the current state of evidence linking a variety of environmental factors and their impact on the emergence of psychotic disorders. The environmental factors include pre- and perinatal insults, stress and trauma, family environment, and cannabis use. The review of evidence is followed by case examples and clinical applications to facilitate the integration of the evidence into clinical practice.
Export Options
About this article
Cite this article as:
Schlosser Danielle A., Pearson Rahel, Perez Veronica B. and Loewy Rachel L., Environmental Risk and Protective Factors and Their Influence on the Emergence of Psychosis , Adolescent Psychiatry 2012; 2 (2) . https://dx.doi.org/10.2174/2210676611202020163
DOI https://dx.doi.org/10.2174/2210676611202020163 |
Print ISSN 2210-6766 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-6774 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Beneficial Effects of Statins on Endothelial Dysfunction and Vascular Stiffness
Current Vascular Pharmacology Heart Failure Pharmacotherapy and Supports in the Elderly - A Short Review
Current Cardiology Reviews Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors
Current Pharmaceutical Design Homocysteine-Lowering Treatment in Coronary Heart Disease
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Auto-Antibodies As Possible Markers and Mediators of Ischemic, Dilated, and Rhythmic Cardiopathies
Current Drug Targets Inducing Tumor Cell Apoptosis: Mediated Survivin miRNA by Ultrasound and Cationic Lipid Contrast Agent
Current Molecular Medicine Ghrelin: A Molecular Target for Weight Regulation, Glucose and Lipid Metabolism
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Patent Selections:
Recent Patents on Cardiovascular Drug Discovery Mouse Mutants of Relaxin, Insulin-Like 3 Peptide and their Receptors
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The Association of Collagenase with Human Diseases and its Therapeutic Potential in Overcoming them
Current Biotechnology The Heart Metabolism: Pathophysiological Aspects in Ischaemia and Heart Failure
Current Pharmaceutical Design <i>Qiliqiangxin</i> Prescription Promotes Angiogenesis of Hypoxic Primary Rat Cardiac Microvascular Endothelial Cells via Regulating miR-21 Signaling
Current Pharmaceutical Design Chlorogenic Acid Suppresses a Cell Adhesion Molecule in Experimental Autoimmune Myocarditis in Mice
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Potential Targets for Intervention in Radiation-Induced Heart Disease
Current Drug Targets OPA1 in Cardiovascular Health and Disease
Current Drug Targets Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends
Current Pharmaceutical Design Clinical Applications for Cardiovascular Magnetic Resonance Imaging at 3 Tesla
Current Cardiology Reviews Gene Therapy for Cardiovascular Diseases
Current Pharmaceutical Design Analgesic Considerations for Liver Transplantation Patients
Current Clinical Pharmacology Potentiating the Naturally Occurring Process for Repair of Damaged Heart
Current Pharmaceutical Design